Bruker Q2 GAAP diluted loss widens to $(0.41) per share; revenue rises 5.2% to $838.5 million year-over-year

PUBT · 1d ago
Bruker Q2 GAAP diluted loss widens to $(0.41) per share; revenue rises 5.2% to $838.5 million year-over-year
  • Bruker Q2 2026 revenue rose 5.2% year-over-year to USD 838.5 million; GAAP diluted EPS turned to a loss of USD 0.41.
  • GAAP operating result swung to a loss of USD 65.3 million, reflecting USD 134.9 million of non-cash goodwill impairment charges.
  • Non-GAAP diluted EPS climbed 53.13% to USD 0.49; non-GAAP operating margin widened 5.1 percentage points to 14.1%.
  • Scientific Instruments bookings increased 10% organically year-over-year with book-to-bill above 1.0x; segment revenue rose 4.7% to USD 767.3 million.
  • FY2026 outlook reaffirmed on operations, with revenue guided at USD 3.54 billion to USD 3.57 billion; non-GAAP EPS seen at USD 2.10 to USD 2.15.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-331511), on August 04, 2026, and is solely responsible for the information contained therein.